Govt plans to upgrade 7 ICU hospitals into super specialty ones: CM Rekha Gupta
Chief Minister Rekha Gupta
on Monday said the government plans to upgrade seven
ICU hospitals
, whose foundations were laid during the COVID-19
pandemic
, into super speciality hospitals.
Speaking at the inauguration of
Yatharth Super Speciality Hospital
in the
Model Town
area here, she said, "There were seven ICU hospitals whose foundations were laid during the pandemic. We have drawn up a plan for them. We will upgrade them into super speciality hospitals."
"One hospital could be for cancer care, one for complicated deliveries, one for treatment of kidney ailments and dialysis," she added and urged private healthcare facilities to get empanelled in
Ayushman Bharat Yojana
.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
She Was Beautiful, Now Its Hard To Look At Her
Crowdy Fan
Undo
The CM also emphasised that there should be awareness about the distinction between primary and secondary healthcare and super speciality hospitals.
"(Sometimes) it happens that if one is suffering from cough or cold, they go to
AIIMS
. A simple cough or cold can also be treated at Arogya Mandir," she explained.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
42 minutes ago
- The Hindu
Global vaccine reserves helped avert 5.8 million infections, over 300,000 deaths since 2000: Study
Global stockpiles of vaccines under programmes supported by 'Gavi, the Vaccine Alliance,' helped prevent more than 5.8 million cases and 327,000 deaths from outbreaks in low- and middle-income countries since 2000, according to a new study. The alliance, established in 2000, funds the roll-out and scale-up of new vaccines through routine healthcare systems and preventive campaigns. The findings, published in the British Medical Journal (BMJ) Global Health, highlight life-saving impacts and economic benefits of nearly USD 32 billion due to outbreak response immunisation programmes aimed at containing vaccine-preventable disease outbreaks. Importance of population immunity, insurance coverage and aid "For diseases with routine vaccination programs, maintaining high levels of population immunity is vital for preventing large outbreaks," lead author Dominic Delport, a PhD candidate at Burnet Institute, an Australian-based medical research institute and NGO said. "But when outbreaks do occur, a rapid vaccine response typically provides the greatest protective impact for the population at risk -- and the faster the response, the greater the impact," Delport said. The researchers added that with routine vaccination declining and also impacted by cuts to the US' foreign aid, the study highlights the ongoing need for an insurance policy against major outbreaks of diseases like cholera, Ebola and measles. The study analysed 210 outbreaks across 49 low- and middle-income countries that occurred between 2000-2023 for five diseases -- cholera, Ebola, measles, meningitis and yellow fever. Challenges in routine vaccine coverage Globally, routine vaccine coverage has been shown to falter, with a recent study published in The Lancet journal attributing this to persistent inequalities, challenges due to the COVID-19 pandemic, and a growth of vaccine misinformation and hesitancy -- factors which increase the risk of vaccine-preventable outbreaks, it said. Low- and middle-income countries have been studied to bear the major brunt of these outbreaks. Senior author Nick Scott, associate professor and head of modelling and biostatistics, Burnet Institute, said the global decline in routine vaccine coverage highlights the value of vaccine stockpiles as insurance against major outbreaks. "Routine vaccine coverage is declining due to many factors including vaccine hesitancy and funding cuts for organisations like USAID and Gavi, and in many places gaps in coverage due to COVID-19 disruptions haven't been filled yet," Scott said. "And as routine coverage declines, the prospect of more major outbreaks means there's a growing need for global vaccine stockpiles," the senior author said. Impact of outbreak immunisation programmes The authors wrote, "Across 210 outbreaks, ORI (outbreak response immunisation) programmes are estimated to have averted 5.81 million cases 327,000 deaths." The team also looked at the impact of outbreak response immunisation programmes in helping control large outbreaks in low- and middle before they became overly disruptive. Larger outbreaks are linked with worse health and economic outcomes, often requiring more disruptive public health measures that involve travel interruptions and school and business closures. "We found here that the presence of the (outbreak response immunisation) consistently resulted in smaller outbreaks (eg, reducing the percentage of measles outbreaks with more than 100,000 cases from 41 per cent to eight per cent)," the authors wrote. "(Outbreak response immunisation) programmes are critical for reducing the health and economic impacts of outbreaks of vaccine-preventable diseases," they wrote.
Time of India
42 minutes ago
- Time of India
‘Fit for discharge, none to care': IMH holds recovered patients; Mental Healthcare Act mandates family reintegration
HYDERABAD: Although around 90 psychiatric patients at the Institute of Mental Health (IMH), Erragadda, have recovered and are deemed fit for reintegration into the community, many continue to remain in the hospital's discharge and cure (DC) ward. Doctors at the IMH report making 25 to 30 phone calls daily to the families of such patients, but to no avail. Relatives or next of kin often refuse to take them back, despite medical clearance. One such case involves a 45-year-old man from Sirpur who was admitted with bipolar affective disorder (BPAD) in December 2023 and declared fit for discharge in April 2024. However, the father of a 15-year-old boy is now being abandoned by his family. A month ago, he also developed a fever and subsequently suffered paralysis. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad 'During his admission, his relatives came along, but now they claim it is his son's responsibility to bring him home. Although his psychiatric condition has improved, he currently has slurred speech (difficulty to pronounce words clearly) and an abnormal gait (change in walking pattern). He needs neurological treatment, but the family refuses to accept him,' said Dr Vivaswan Boorla, psychiatrist at IMH. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like For the chosen ones! 4&5 Bed Condominiums at Financial District, Hyd Sumadhura Group Learn More Undo On average, patients are recommended for discharge within three to four months, unless they have a chronic mental illness, in which case treatment typically lasts six to seven months. Most of the patients suffer from conditions such as schizophrenia, bipolar disorder, and other psychological illnesses. OVERUSE OF HOSP RESOURCES Telangana currently has two mental health review boards (MHRBs), which oversee discharge procedures via dedicated committees. While some recovered patients have been placed in care homes run by non-profits, this is only permitted through court orders. The situation is also contributing to the overuse of hospital resources and adding strain to IMH's 600-bed capacity. 'Beds and other resources continue to be occupied by patients who are already fit for discharge, even as new patients are admitted regularly. This often results in a shortage of space and puts additional pressure on the hospital staff,' said a senior doctor. Moreover, due to extended stays, many recovered patients in the DC ward begin to develop general health issues such as fever, cough, hypertension, and diabetes. 'These patients need to be taken to specialists at Osmania General Hospital (OGH) and other facilities, usually accompanied by a staff member in an ambulance. This adds further pressure on our staff,' the doctor added. Several of these patients were also taken ill during the food poisoning incident at IMH in early June. Citing the Mental Healthcare Act 2017, IMH superintendent Dr Anitha Rayirala emphasised that the law mandates the reintegration of recovered psychiatric patients into society. She added that the primary aim of the revised Act was to uphold the rights of individuals with mental illness, who were frequently abandoned in the past. 'The patients in DC wards have been granted the status of free citizens on court orders. Yet, there remains a widespread belief among family members that these individuals are still unwell, even when they are stable and doing well post-treatment. Another issue is that families often stop administering medication after discharge, leading to relapse. Family Unwilling A 46-year-old man from Pedadapally was admitted to the IMH in June 2019 following a magistrate's order and was declared fit for discharge in October 2020. According to doctors, the patient had discontinued his psychiatric medication on his own, claiming he was asymptomatic and no longer required treatment. However, due to his history of aggression and the potential risk he poses to his elderly parents, particularly in light of his mother's medical condition and his father's caregiving responsibilities, the family has expressed their unwillingness and inability to take him back home post-discharge. Fears Of Relapse In another case, a 36-year-old man from Mancherial diagnosed with bipolar affective disorder (BPAD) was admitted to the IMH in September 2024 and declared fit for discharge two months later. Despite repeated calls, his family members have expressed reluctance to take him home, citing fears of a potential relapse. While they assured the patient over the phone that they would visit soon, they have since informed the doctors that they do not intend to come.
Time of India
an hour ago
- Time of India
Need a testosterone boost? New study suggests trying weight-loss drugs like Ozempic
We're circling back to the age-old idea of hitting two birds with one stone! The medication that's widely prescribed to manage diabetes and used for weight loss as well – is now showing promise to offer some more exceptional health perks. Recent research suggests that GLP‑1 receptor agonists, like Ozempic, Wegovy, Mounjaro, and Trulicity, might offer an unexpected hormonal benefit. A recently presented ENDO 2025 study tracked 110 men over 18 months, revealing a remarkable rise in testosterone from 53% to 77% of normal levels, alongside about 10% average weight loss. These findings hint that by targeting fat reduction, insulin resistance, inflammation, and estrogen-to-testosterone conversion, these drugs could offer a dual boost for metabolic and men's health. Read on to know more. The GLP‑1–Testosterone breakthrough GLP‑1 receptor agonists – such as semaglutide (Ozempic/Wegovy), dulaglutide (Trulicity), and tirzepatide (Mounjaro/Zepbound) – work by mimicking the gut hormone GLP‑1 to suppress appetite, slow digestion, and improve insulin secretion. Now, testosterone is a hormone that fuels male sex drive and erectile function and influences everything from bone density and muscle mass to fat distribution, red blood cell production, mood, and energy levels. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like นี่อาจเป็นโอกาสทองที่ดีที่สุดในรอบ 5 ปีสำหรับการเทรดทองคำ IC Markets อ่านเพิ่มเติม Undo Unfortunately, testosterone levels naturally decline with age. Older men may feel more tired and grouchy, and less interested in sex. Not to mention the hair loss, bone fractures, and weight gain around the waist that often accompany low T. Luckily, there are ways to naturally boost testosterone. Exercise, especially strength training, a healthy diet, stress reduction, adequate sleep, and weight management, particularly for those who are overweight, are just a few. This new study highlights another tool that may help elevate these levels — Ozempic and other GLP-1 drugs. Endocrinology fellow Dr. Shellsea Portillo Canales and the research team analyzed the records of 110 adult men with obesity or Type 2 diabetes taking the weight-loss medications semaglutide (Wegovy), dulaglutide (Trulicity), or tirzepatide (Zepbound) but not participating in testosterone or hormonal therapy. These three drugs mimic the effects of GLP-1, a natural hormone in the body that regulates blood sugar and appetite, often leading to lower blood sugar and weight loss. At the ENDO 2025 conference , the team shared data showing men on these drugs experienced ~10% weight loss and significant testosterone increases (from 53% to 77% of normal) over 18 months. Mechanisms include reduced aromatase in shrinking fat, improved insulin sensitivity, and lower systemic inflammation – key drivers supporting testosterone production. The convincing evidence A 2025 meta-analysis (n=680) of seven GLP‑1 RA trials found a pooled increase in total testosterone of 1.39 ng/mL, with parallel gains in free testosterone, LH, FSH, weight loss, and HbA1c reduction. Liraglutide (Saxenda) was observed to restore gonadotropin signaling and improve testosterone in obese men, without the hormonal axis suppression typical of testosterone replacement therapy. However, a 2021 cohort in men with type 2 diabetes (n=51) showed only modest testosterone increases, primarily in men whose baseline testosterone was under 320 ng/dL or had ≥1% HbA1c reduction, reinforcing the importance of weight loss and insulin control. How does weight impact testosterone levels in males? In men, weight, particularly excess body fat, is inversely related to testosterone levels. Increased body fat, especially around the abdomen, is associated with lower testosterone, while weight loss, particularly through lifestyle changes, can lead to increased testosterone levels. As per research , weight loss can enhance testosterone levels because excess body fat contains the enzyme aromatase, which converts testosterone into estrogen. As reported by the NY Post, Dr. Shellsea Portillo Canales, an endocrinology fellow at SSM Health St. Louis University Hospital in Missouri, said, 'While it is well-known that weight loss from lifestyle changes or bariatric surgery increases testosterone levels, the impact that anti-obesity medications may also have on these levels has not been widely studied,' adding, 'Our study is among the first to provide compelling evidence that low testosterone can be reversed with the use of commonly prescribed anti-obesity medications. ' Portillo Canales also said, 'Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,' adding, 'Doctors and their patients can now consider this class of medications not only for the treatment of obesity and to control blood sugar, but also to benefit men's reproductive health.' The way ahead Although initial findings from ENDO 2025 and earlier trials are encouraging, longer randomized controlled trials (RCTs) are essential to confirm direct effects on fertility, muscle mass, mood, and safety of GLP‑1 therapies. If you're considering a testosterone boost without traditional hormone therapy, GLP‑1 agents like Ozempic may offer a compelling path: addressing weight, metabolic health – and testosterone – together. Talk to your endocrinologist to explore whether this novel approach fits your needs and goals. Always approach treatment under medical guidance – monitoring weight, hormones, metabolic health, fertility, and side effects. Study suggests digital apps can help chronic pain sufferers
